LungVax: Preventing lung cancer via targeting hotspot neoantigens with the ChAdOx vaccine platform

Funder	Cancer Research UK
Recipient Organization	University of Oxford
Country	United Kingdom
Start Date	Mar 01, 2024
End Date	Feb 28, 2026
Duration	729 days
Number of Grantees	1
Roles	Award Holder
Data Source	Europe PMC
Grant ID	`PRCBTP-Nov23/100003`

Grant Description

Background: Low-dose CT screening has proved effective at reducing lung-cancer mortality (PMID:31995683) in population subgroups at highest risk of lung cancer (current/former-smokers). While effective,